コロナ飲み薬「対策の決め手に」　岸田首相、治験の現場視察

　岸田文雄首相は１０日、新型コロナウイルス経口薬の臨床試験（治験）を行っている横浜市内の宿泊療養施設を視察した。塩野義製薬の手代木功社長から、投薬方法などについて説明を受けた後、健康観察の様子などを見学。視察後、記者団に「コロナ対策の大きな決め手となる取り組みだ」と語り、早期実用化に期待を示した。（2021/10/10-15:35）

Japanese Prime Minister Fumio Kishida on Sunday visited a facility where Shionogi & Co. is conducting a clinical trial for its orally taken novel coronavirus drug.
   At the accommodation facility designated as a place to host COVID-19 patients in Yokohama, Kanagawa Prefecture, south of Tokyo, Kishida received explanations from Shionogi President Isao Teshirogi about how the new drug is being administered and observed the way a patient's health is being monitored.
   "This is an effort that will be key to overcoming the coronavirus crisis," the prime minister told reporters after the visit, expressing hope that the oral COVID-19 drug will be put into practical use at an early date.
   Touching on the fact that the number of coronavirus patients staying at home across Japan exceeded 130,000 in September, Kishida said: "We must prevent something like this from happening again. For that purpose, an oral drug would be crucial."